Overview

Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Healthy Men

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This randomized phase I trial is studying the side effects and best dose of Bowman-Birk inhibitor concentrate in preventing cancer in healthy men. Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of Bowman-Birk inhibitor concentrate may prevent cancer.
Phase:
Phase 1
Details
Lead Sponsor:
National Cancer Institute (NCI)